Showing results (81-90 of 152) with videos related to
Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancerAthanassios Argiris, Michalis V Karamouzis, William E Gooding, et al.International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancerMatthew C Biagioli, Mark Harvey, Eloy Roman, et al.Expert Opinion on Investigational Drugs|June 25, 2013
BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancerChristian Rolfo, Luis E Raez, Giuseppe Bronte, et al.Cancer Chemotherapy and Pharmacology|September 24, 2013
A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)Luis E Raez, Edgardo S Santos, R Timothy Webb, et al.International Journal of Molecular Sciences|February 24, 2024
Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various CancersKhine S Shan, Amalia Bonano-Rios, Nyein Wint Yee Theik, et al.Head & Neck|March 25, 2009
Radiation technique influence on percutaneous endoscopic gastrostomy tube dependence: Comparison between two radiation schemesGeorges F Hatoum, Andre Abitbol, Inas Elattar, et al.Clinical Lung Cancer|December 30, 2022
Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)Luis E Raez, Kayla Brice, Katerine Dumais, et al.Critical Reviews in Oncology/Hematology|March 11, 2016
BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?Rafael Caparica, Gilberto de Castro, Ignacio Gil-Bazo, et al.Cancer Gene Therapy|November 8, 2003
Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinomaLuis E Raez, Peter A Cassileth, James J Schlesselman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancerLuis E Raez, Peter A Cassileth, James J Schlesselman, et al.Pageof 16